Skip to main content

Comparative Effectiveness in Colon and Rectal Cancer

  • Chapter
  • First Online:
Comparative Effectiveness in Surgical Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 164))

Abstract

Treatment of colorectal cancer is becoming more uniform, with wider acceptance of standardized guidelines. However, areas of controversy exist where the appropriate treatment is not clear, including:

  • should a segmental colectomy or a more extensive resection be performed in hereditary nonpolyposis colorectal cancer?

  • should an asymptomatic primary cancer be resected in the presence of unresectable metastatic disease?

  • what is the role of extended lymph node resection in colon and rectal cancer?

  • are there clinically significant benefits for a robotic approach to colorectal resection versus a laparoscopic approach?

This chapter will examine these issues and discuss how they may be resolved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, Watson PA, Lanspa SJ, Marcus JN et al (1987) Recognition and treatment of patients with hereditary nonpolyposis colon cancer (lynch syndromes i and ii). Ann Surg 206:289–295

    Article  PubMed Central  PubMed  Google Scholar 

  2. Kalady MF, Lipman J, McGannon E, Church JM (2012) Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255:1121–1125

    Article  PubMed  Google Scholar 

  3. Rijcken FE, Hollema H, Kleibeuker JH (2002) Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 50:382–386

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834

    Article  CAS  PubMed  Google Scholar 

  5. Kalady MF, McGannon E, Vogel JD, Manilich E, Fazio VW, Church JM (2010) Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 252:507–511 discussion 511–503

    PubMed  Google Scholar 

  6. Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M et al (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with lynch syndrome. Gastroenterology 138:2300–2306

    Article  PubMed  Google Scholar 

  7. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK et al (2008) Missed adenomas during colonoscopic surveillance in individuals with lynch syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res 1:470–475

    Article  Google Scholar 

  8. Network NCC (2014) Nccn clinical practice guidlines in oncology: colon cancer

    Google Scholar 

  9. Mecklin JP, Jarvinen H (1993) Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 36:927–929

    Article  CAS  PubMed  Google Scholar 

  10. Van Dalen R, Church J, McGannon E, Fay S, Burke C, Clark B (2003) Patterns of surgery in patients belonging to amsterdam-positive families. Dis Colon Rectum 46:617–620

    Article  PubMed  Google Scholar 

  11. Maeda T, Cannom RR, Beart RW Jr, Etzioni DA (2010) Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin Oncol (official journal of the American Society of Clinical Oncology) 28:1175–1180

    Article  Google Scholar 

  12. de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, Cats A, Menko FH, Griffioen G, et al (2003) Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52:1752–1755

    Google Scholar 

  13. Lee JS, Petrelli NJ, Rodriguez-Bigas MA (2001) Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg 181:207–210

    Article  CAS  PubMed  Google Scholar 

  14. Kalady MF (2011) Surgical management of hereditary nonpolyposis colorectal cancer. Adv Surg 45:265–274

    Article  PubMed  Google Scholar 

  15. Thorson AG, Faria J (2000) Familial adenomatous polyposis, hereditary nonpolyposis colon cancer, and familial risk: what are the implications for the surgeon? Surg Oncol Clin N Am 9:683–697 discussion 699–701

    CAS  PubMed  Google Scholar 

  16. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM (1998) Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 129:787–796

    Article  CAS  PubMed  Google Scholar 

  17. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244:254–259

    Article  PubMed Central  PubMed  Google Scholar 

  18. McCahill LE, Yothers G, Sharif S, Petrelli NJ, Lai LL, Bechar N et al (2012) Primary mfolfox6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of nsabp trial c-10. Journal Clin Oncol (official journal of the American Society of Clinical Oncology) 30:3223–3228

    Article  CAS  Google Scholar 

  19. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD (2003) Elective bowel resection for incurable stage iv colorectal cancer: Prognostic variables for asymptomatic patients. J Am Coll Surg 196:722–728

    Article  PubMed  Google Scholar 

  20. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD (1999) Nonoperative management of primary colorectal cancer in patients with stage iv disease. Ann Surg Oncol 6:651–657

    Article  CAS  PubMed  Google Scholar 

  21. Cirocchi R, Trastulli S, Abraha I, Vettoretto N, Boselli C, Montedori A et al (2012) Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage iv colorectal cancer. Cochrane Database Syst Rev 8:CD008997

    PubMed  Google Scholar 

  22. Muratore A, Zorzi D, Bouzari H, Amisano M, Massucco P, Sperti E et al (2007) Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 14:766–770

    Article  PubMed  Google Scholar 

  23. Stelzner S, Hellmich G, Koch R, Ludwig K (2005) Factors predicting survival in stage iv colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 89:211–217

    Article  PubMed  Google Scholar 

  24. Cellini C, Hunt SR, Fleshman JW, Birnbaum EH, Bierhals AJ, Mutch MG (2010) Stage iv rectal cancer with liver metastases: is there a benefit to resection of the primary tumor? World J Surg 34:1102–1108

    Article  PubMed  Google Scholar 

  25. Vibert E, Bretagnol F, Alves A, Pocard M, Valleur P, Panis Y (2007) Multivariate analysis of predictive factors for early postoperative death after colorectal surgery in patients with colorectal cancer and synchronous unresectable liver metastases. Dis Colon Rectum 50:1776–1782

    Article  PubMed  Google Scholar 

  26. Galizia G, Lieto E, Orditura M, Castellano P, Imperatore V, Pinto M et al (2008) First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 143:352–358 discussion 358

    Article  PubMed  Google Scholar 

  27. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B (2005) Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Sur 92:1155–1160

    Article  CAS  Google Scholar 

  28. Seo GJ, Park JW, Yoo SB, Kim SY, Choi HS, Chang HJ et al (2010) Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage iv colorectal cancer. J Surg Oncol 102:94–99

    Article  PubMed  Google Scholar 

  29. Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J et al (2003) Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 52:568–573

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Platell C, Ng S, O’Bichere A, Tebbutt N (2011) Changing management and survival in patients with stage iv colorectal cancer. Dis Colon Rectum 54:214–219

    Article  PubMed  Google Scholar 

  31. Karoui M, Roudot-Thoraval F, Mesli F, Mitry E, Aparicio T, Des Guetz G et al (2011) Primary colectomy in patients with stage iv colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum 54:930–938

    Article  PubMed  Google Scholar 

  32. Konyalian VR, Rosing DK, Haukoos JS, Dixon MR, Sinow R, Bhaheetharan S et al (2007) The role of primary tumour resection in patients with stage iv colorectal cancer. Colorectal Dis Official J Assoc Coloproctol Great Br Irel 9:430–437

    Article  CAS  Google Scholar 

  33. Zhang S, Gao F, Luo J, Yang J (2010) Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis. Colorectal Dis Official J Assoc Coloproctol Great Br Irel 12:754–761

    Article  CAS  Google Scholar 

  34. Obichere A (2012) Chemotherapy with or without surgery in treating patients with metastatic colorectal cancer that cannot be removed by surgery. Clinicaltrials. Gov study number nct01086618

    Google Scholar 

  35. Platell C (2012) A randomised phase iii multicenter trial evaluating the role of palliative surgical resection of the primary tumour in patients with metastatic colorectal cancer. Actrn12609000680268

    Google Scholar 

  36. Rahbari NN, Lordick F, Fink C, Bork U, Stange A, Jager D et al (2012) Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (uicc stage iv): synchronous–a randomised controlled multicentre trial (isrctn30964555). BMC Cancer 12:142

    Article  PubMed Central  PubMed  Google Scholar 

  37. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225

    Article  PubMed  Google Scholar 

  38. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis Official J Assoc Coloproctol Great Br Irel 11:354–364 discussion 364–355

    Article  CAS  Google Scholar 

  39. West NP, Kobayashi H, Takahashi K, Perrakis A, Weber K, Hohenberger W et al (2012) Understanding optimal colonic cancer surgery: comparison of japanese d3 resection and european complete mesocolic excision with central vascular ligation. J Clin Oncol (official journal of the American Society of Clinical Oncology) 30:1763–1769

    Article  Google Scholar 

  40. West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P (2010) Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol (official journal of the American Society of Clinical Oncology) 28:272–278

    Article  Google Scholar 

  41. Adamina M, Manwaring ML, Park KJ, Delaney CP (2012) Laparoscopic complete mesocolic excision for right colon cancer. Surg Endosc 26:2976–2980

    Article  PubMed  Google Scholar 

  42. Weber K, Merkel S, Perrakis A, Hohenberger W (2013) Is there a disadvantage to radical lymph node dissection in colon cancer? Int J Colorectal Dis 28:217–226

    Article  CAS  PubMed  Google Scholar 

  43. Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC (2003) Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 46:860–866

    Article  CAS  PubMed  Google Scholar 

  44. West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P (2008) Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 9:857–865

    Article  PubMed  Google Scholar 

  45. Jagoditsch M, Lisborg PH, Jatzko GR, Wette V, Kropfitsch G, Denk H et al (2000) Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical, and pathologic variables. World J Surg 24:1264–1270

    Article  CAS  PubMed  Google Scholar 

  46. Spasojevic M, Stimec BV, Gronvold LB, Nesgaard JM, Edwin B, Ignjatovic D (2011) The anatomical and surgical consequences of right colectomy for cancer. Dis Colon Rectum 54:1503–1509

    Article  PubMed  Google Scholar 

  47. Toyota S, Ohta H, Anazawa S (1995) Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum 38:705–711

    Article  CAS  PubMed  Google Scholar 

  48. Dong XS, Xu HT, Yu ZW, Liu M, Cu BB, Zhao P et al (2003) Effect of extended radical resection for rectal cancer. World J Gastroenterol WJG 9:970–973

    Google Scholar 

  49. Shiozawa M, Akaike M, Yamada R, Godai T, Yamamoto N, Saito H et al (2007) Lateral lymph node dissection for lower rectal cancer. Hepatogastroenterology 54:1066–1070

    PubMed  Google Scholar 

  50. Col C, Hasdemir O, Yalcin E, Guzel H, Tunc G, Bilgen K et al (2005) The assessment of urinary function following extended lymph node dissection for colorectal cancer. Eur J Surg Oncolo Journal Eur Soc Sur Oncol Br Assoc Sur Oncol 31:237–241

    CAS  Google Scholar 

  51. Hasdemir O, Col C, Yalcin E, Tunc G, Bilgen K, Kucukpinar T (2005) Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer. Hepatogastroenterology 52:455–459

    PubMed  Google Scholar 

  52. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ et al (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10:1053–1062

    Article  PubMed  Google Scholar 

  53. Watanabe T, Tsurita G, Muto T, Sawada T, Sunouchi K, Higuchi Y et al (2002) Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 132:27–33

    Article  PubMed  Google Scholar 

  54. Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16:2779–2786

    Article  PubMed  Google Scholar 

  55. Matsuoka N, Moriya Y, Akasu T, Fujita S (2001) Long-term outcome of urinary function after extended lymphadenectomy in patients with distal rectal cancer. Eur J Sur Oncol J Eur Soc Sur Oncol Br Assoc Sur Oncol 27:165–169

    CAS  Google Scholar 

  56. Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21:728–732

    Article  CAS  PubMed  Google Scholar 

  57. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T et al (2001) Randomized, controlled trial of lateral node dissectionvs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44:1274–1280

    Article  CAS  PubMed  Google Scholar 

  58. Rea JD, Cone MM, Diggs BS, Deveney KE, Lu KC, Herzig DO (2011) Utilization of laparoscopic colectomy in the United States before and after the clinical outcomes of surgical therapy study group trial. Ann Surg 254:281–288

    Article  PubMed  Google Scholar 

  59. Luca F, Cenciarelli S, Valvo M, Pozzi S, Faso FL, Ravizza D et al (2009) Full robotic left colon and rectal cancer resection: technique and early outcome. Ann Surg Oncol 16:1274–1278

    Article  PubMed  Google Scholar 

  60. Delaney CP, Lynch AC, Senagore AJ, Fazio VW (2003) Comparison of robotically performed and traditional laparoscopic colorectal surgery. Dis Colon Rectum 46:1633–1639

    Article  PubMed  Google Scholar 

  61. deSouza AL, Prasad LM, Park JJ, Marecik SJ, Blumetti J, Abcarian H (2010) Robotic assistance in right hemicolectomy: is there a role? Dis Colon Rectum 53:1000–1006

    Article  PubMed  Google Scholar 

  62. deSouza AL, Prasad LM, Ricci J, Park JJ, Marecik SJ, Zimmern A et al (2011) A comparison of open and robotic total mesorectal excision for rectal adenocarcinoma. Dis Colon Rectum 54:275–282

    Article  PubMed  Google Scholar 

  63. Fung AK, Aly EH (2013) Robotic colonic surgery: is it advisable to commence a new learning curve? Dis Colon Rectum 56:786–796

    Article  PubMed  Google Scholar 

  64. Kwak JM, Kim SH, Kim J, Son DN, Baek SJ, Cho JS (2011) Robotic versus laparoscopic resection of rectal cancer: short-term outcomes of a case-control study. Dis Colon Rectum 54:151–156

    Article  PubMed  Google Scholar 

  65. Park JS, Choi GS, Park SY, Kim HJ, Ryuk JP (2012) Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. The British journal of surgery. 99:1219–1226

    Article  CAS  PubMed  Google Scholar 

  66. Patel CB, Ragupathi M, Ramos-Valadez DI, Haas EM (2011) A three-arm (laparoscopic, hand-assisted, and robotic) matched-case analysis of intraoperative and postoperative outcomes in minimally invasive colorectal surgery. Dis Colon Rectum 54:144–150

    Article  PubMed  Google Scholar 

  67. Scarpinata R, Aly EH (2013) Does robotic rectal cancer surgery offer improved early postoperative outcomes? Dis Colon Rectum 56:253–262

    Article  PubMed  Google Scholar 

  68. Baek SJ, Al-Asari S, Jeong DH, Hur H, Min BS, Baik SH et al (2013) Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer. Surg Endosc 27:4157–4163

    Article  PubMed  Google Scholar 

  69. Bianchi PP, Ceriani C, Locatelli A, Spinoglio G, Zampino MG, Sonzogni A et al (2010) Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc 24:2888–2894

    Article  CAS  PubMed  Google Scholar 

  70. D’Annibale A, Morpurgo E, Fiscon V, Trevisan P, Sovernigo G, Orsini C et al (2004) Robotic and laparoscopic surgery for treatment of colorectal diseases. Dis Colon Rectum 47:2162–2168

    Article  PubMed  Google Scholar 

  71. Trastulli S, Desiderio J, Farinacci F, Ricci F, Listorti C, Cirocchi R et al (2013) Robotic right colectomy for cancer with intracorporeal anastomosis: short-term outcomes from a single institution. Int J Colorectal Dis 28:807–814

    Article  PubMed  Google Scholar 

  72. Patriti A, Ceccarelli G, Bartoli A, Spaziani A, Biancafarina A, Casciola L (2009) Short- and medium-term outcome of robot-assisted and traditional laparoscopic rectal resection. JSLS J Soc Laparoendosc Surg/Soc Laparoendosc Surg 13:176–183

    Google Scholar 

  73. Tyler JA, Fox JP, Desai MM, Perry WB, Glasgow SC (2013) Outcomes and costs associated with robotic colectomy in the minimally invasive era. Dis Colon Rectum 56:458–466

    Article  PubMed  Google Scholar 

  74. Trastulli S, Farinella E, Cirocchi R, Cavaliere D, Avenia N, Sciannameo F et al (2012) Robotic resection compared with laparoscopic rectal resection for cancer: systematic review and meta-analysis of short-term outcome. Colorectal Dis Official J Assoc Coloproctol Great Br Irel 14:e134–e156

    Article  CAS  Google Scholar 

  75. Robotic versus laparoscopic resection for rectal cancer (rolarr) trial. Online at http://ctru.Leeds.Ac.Uk/rolarr

  76. Baik SH, Kim NK, Lim DR, Hur H, Min BS, Lee KY (2013) Oncologic outcomes and perioperative clinicopathologic results after robot-assisted tumor-specific mesorectal excision for rectal cancer. Ann Surg Oncol 20:2625–2632

    Article  PubMed  Google Scholar 

  77. Choi DJ, Kim SH, Lee PJ, Kim J, Woo SU (2009) Single-stage totally robotic dissection for rectal cancer surgery: technique and short-term outcome in 50 consecutive patients. Dis Colon Rectum 52:1824–1830

    Article  PubMed  Google Scholar 

  78. Pigazzi A, Luca F, Patriti A, Valvo M, Ceccarelli G, Casciola L et al (2010) Multicentric study on robotic tumor-specific mesorectal excision for the treatment of rectal cancer. Ann Surg Oncol 17:1614–1620

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine C. Jensen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jensen, C.C., Madoff, R.D. (2015). Comparative Effectiveness in Colon and Rectal Cancer. In: Bilimoria, K., Minami, C., Mahvi, D. (eds) Comparative Effectiveness in Surgical Oncology. Cancer Treatment and Research, vol 164. Springer, Cham. https://doi.org/10.1007/978-3-319-12553-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12553-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-12552-7

  • Online ISBN: 978-3-319-12553-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics